Nrxn1tm1d(KOMP)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Nrxn1tm1d(KOMP)Wtsi |
| Name: |
neurexin I; targeted mutation 1d, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:8161771 |
| Gene: |
Nrxn1 Location: Chr17:90341059-91400499 bp, - strand Genetic Position: Chr17, 59.73 cM
|
| Alliance: |
Nrxn1tm1d(KOMP)Wtsi page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:148605
|
| Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
| Strain of Origin: |
C57BL/6N-Atm1Brd
|
|
| Allele Type: |
|
Targeted (Null/knockout) |
| Mutations: |
|
Insertion, Intragenic deletion
|
| |
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 90950152 of Chromosome 17 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 90951300. The critical exon(s) is/are thus flanked by loxP sites. Flp-mediated recombination removed the lacZ and neomycin resistance gene. Cre-mediated recombination deleted critical exon(s) and generated a knockout mouse. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml.
(J:148605)
|
|
|
|
|
| Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
| All: |
1 reference(s) |
|